Category: Calendar, Events

[vc_row][vc_column][vc_column_text] In 2023 ESMO TAT will be dedicated to improving the conduct of early anti-cancer clinical trials, bringing together those who are developing the most promising new cancer drugs and unveiling exciting new data. Stakeholders from academia and industry will discuss with clinicians, researchers, and regulators the global dissemination of knowledge and clinical research expertise

Tuesday, January 31, 2022, 11:00 am, IGMM conference room “Bcl2 family members in colorectal cancer” Prof. Jan Paul Medema, Cancer Center, Amsterdam Jan Paul’s group made major contributions in the field of colorectal cancer. Some of their recent publications: Di Franco, S., Bianca, P., Sardina, D.S., Turdo, A., Gaggianesi, M., Veschi, V., Nicotra, A., Mangiapane, L.R.,